LANCET ONCOLOGY (ONLINE)

Journal

Identifier:

E258456

ISSN:

1474-5488

Overview

Outputs

Four-year follow-up and re-treatment of mesothelioma patients with combined tremelimumab and durvalumab: the NIBIT-MESO-1 study

Academic Article

No Results Found